| SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders |
Globe Newswire |
04/17 |
16:05 |
| Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026 |
Globe Newswire |
04/17 |
16:05 |
| QuasarEdge Acquisition Corporation Announces Exercise of Over-Allotment Option |
Globe Newswire |
04/17 |
16:05 |
| VALUE LINE, INC. DIVIDEND HAS JUST BEEN RAISED FROM $1.30 TO $1.40 (ANNUALIZED) – ITS 12TH CONSECUTIVE INCREASE |
Globe Newswire |
04/17 |
16:03 |
| Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares |
Globe Newswire |
04/17 |
16:02 |
| Hingham Savings Reports First Quarter 2026 Results |
Globe Newswire |
04/17 |
16:01 |
| New Era Energy & Digital Announces Appointment of Andy Casazza as Chief Corporate Officer |
Globe Newswire |
04/17 |
16:01 |
| Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting |
Globe Newswire |
04/17 |
16:01 |
| Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2 |
Globe Newswire |
04/17 |
16:01 |
| Acrivon to Highlight Preclinical Data with Three Posters at AACR Demonstrating Strong ACR-368 and ACR-2316 Synergies with Immune Checkpoint Inhibitors and ADC Payloads, Revealing Broad Clinical Development Opportunities |
Globe Newswire |
04/17 |
16:00 |
| Freshpet Inc. (NASDAQ: FRPT) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C. |
Globe Newswire |
04/17 |
15:53 |
| Genesis Revival Claims Evaluated: Analyzing the Pineal Gland Support Ingredients, Side Effects Risk and User Complaints |
Globe Newswire |
04/17 |
15:48 |
| MLG Capital Recognized by National Multifamily Housing Council as a 2026 Top 50 Owner |
Globe Newswire |
04/17 |
15:40 |
| Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm |
Globe Newswire |
04/17 |
15:20 |
| OneMain Holdings, Inc. (NYSE: OMF) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C. |
Globe Newswire |
04/17 |
15:15 |
| Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026 |
Globe Newswire |
04/17 |
15:15 |
| Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial |
Globe Newswire |
04/17 |
15:10 |
| Surgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details |
Globe Newswire |
04/17 |
15:08 |
| Brazilian Wood Claims Evaluated: Discover the Male Enhancement Hardening Pill Truth by SuperNatural Man |
Globe Newswire |
04/17 |
15:07 |
| Kairos Power Breaks Ground on Hermes 2 Demonstration Plant |
Globe Newswire |
04/17 |
15:06 |
| Trump's lawyers are in talks with the IRS to resolve president's $10B lawsuit |
AP Online |
04/17 |
15:01 |
| Crestwood Advisors Named Once Again to USA TODAY’s 2026 Best Financial Advisory Firms List |
Globe Newswire |
04/17 |
15:00 |
| New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma |
Globe Newswire |
04/17 |
15:00 |
| PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma |
Globe Newswire |
04/17 |
15:00 |
| Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform |
Globe Newswire |
04/17 |
15:00 |
